{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:17:43Z","timestamp":1794953863073,"version":"4.9.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82500094"],"award-info":[{"award-number":["82500094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.isci.2026.117098","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:27:57Z","timestamp":1785770877000},"page":"117098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative multi-omics reveals a prognostic and therapeutic landscape of synthetic lethality-associated signatures in lung adenocarcinoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Zerong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117098_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small-cell lung cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.117098_bib2","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1200\/JCO.2005.15.776","article-title":"Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma","volume":"23","author":"Travis","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117098_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107525","article-title":"Role of the ERO1-PDI interaction in oxidative protein folding and disease","volume":"210","author":"Shergalis","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2026.117098_bib4","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.3390\/cells11203200","article-title":"Biomarker-Targeted Therapies in Non-Small Cell Lung Cancer: Current Status and Perspectives","volume":"11","author":"Guo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.117098_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030384","article-title":"Immune Resistance in Lung Adenocarcinoma","volume":"13","author":"Spella","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2026.117098_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1275957","article-title":"Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy","volume":"14","author":"Zeng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117098_bib7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: Synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.117098_bib8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1158\/0008-5472.CAN-23-0628","article-title":"BRCAness, Homologous Recombination Deficiencies, and Synthetic Lethality","volume":"83","author":"Murai","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117098_bib9","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/s41588-023-01557-x","article-title":"Complex synthetic lethality in cancer","volume":"55","author":"Ryan","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.117098_bib10","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1158\/2159-8290.CD-20-1503","article-title":"Synthetic Lethality in Cancer Therapeutics: The Next Generation","volume":"11","author":"Setton","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.117098_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41573-019-0046-z","article-title":"Synthetic lethality as an engine for cancer drug target discovery","volume":"19","author":"Huang","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.117098_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.trecan.2018.11.001","article-title":"A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic Lethality","volume":"5","author":"Parameswaran","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.isci.2026.117098_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217010","article-title":"Methylation synthetic lethality: Exploiting selective drug targets for cancer therapy","volume":"597","author":"Ye","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.117098_bib14","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1097\/JS9.0000000000002639","article-title":"Integrating computational pathology and multi-transcriptomics to characterize lung adenocarcinoma heterogeneity and prognostic modeling","volume":"111","author":"Li","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.isci.2026.117098_bib15","article-title":"Transparency In The reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Premier J. Sci."},{"key":"10.1016\/j.isci.2026.117098_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s13311-018-00704-1","article-title":"Prostaglandin A1 Inhibits the Cognitive Decline of APP\/PS1 Transgenic Mice via PPAR\u03b3\/ABCA1-dependent Cholesterol Efflux Mechanisms","volume":"16","author":"Xu","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.isci.2026.117098_bib17","doi-asserted-by":"crossref","first-page":"5249086","DOI":"10.1155\/2016\/5249086","article-title":"An Update of Microsomal Prostaglandin E Synthase-1 and PGE2 Receptors in Cardiovascular Health and Diseases","volume":"2016","author":"Yang","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.isci.2026.117098_bib18","doi-asserted-by":"crossref","first-page":"18522","DOI":"10.1074\/jbc.273.29.18522","article-title":"Potent prostaglandin A1 analogs that suppress tumor cell growth through induction of p21 and reduction of cyclin E","volume":"273","author":"Tanikawa","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.117098_bib19","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41591-018-0177-5","article-title":"Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning","volume":"24","author":"Coudray","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.117098_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-022-01519-7","article-title":"Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma","volume":"21","author":"Song","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2026.117098_bib21","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232028","article-title":"EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation","volume":"221","author":"Qin","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2026.117098_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107860","article-title":"ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project","volume":"194","author":"Speel","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.isci.2026.117098_bib23","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.cell.2021.03.030","article-title":"Synthetic lethality-mediated precision oncology via the tumor transcriptome","volume":"184","author":"Lee","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117098_bib24","article-title":"Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPAR\u03b3 signalling pathway","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117098_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA Damage Response in Cancer","volume":"60","author":"O'Connor","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.117098_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117098_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jmcb\/mjq057","article-title":"Genomic instability and cancer: an introduction","volume":"3","author":"Shen","year":"2011","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.117098_bib28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ajhg.2013.06.015","article-title":"Mutations in CYC1, encoding cytochrome c1 subunit of respiratory chain complex III, cause insulin-responsive hyperglycemia","volume":"93","author":"Gaignard","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.isci.2026.117098_bib29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/labinvest.2017.113","article-title":"NME4\/nucleoside diphosphate kinase D in cardiolipin signaling and mitophagy","volume":"98","author":"Schlattner","year":"2018","journal-title":"Lab. Invest."},{"key":"10.1016\/j.isci.2026.117098_bib30","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0021-9258(17)37733-5","article-title":"Cytochrome c1 complexes","volume":"254","author":"Chiang","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.117098_bib31","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/cas.13251","article-title":"Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis","volume":"108","author":"Chishiki","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.isci.2026.117098_bib32","first-page":"1365","article-title":"Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinoma","volume":"34","author":"Sato","year":"2019","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.isci.2026.117098_bib33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.molcel.2023.12.008","article-title":"Dual regulation of SLC25A39 by AFG3L2 and iron controls mitochondrial glutathione homeostasis","volume":"84","author":"Shi","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.117098_bib34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.molcel.2023.12.037","article-title":"SLC25A39 links mitochondrial GSH sensing with iron metabolism","volume":"84","author":"Chen","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.117098_bib35","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.7150\/jca.98844","article-title":"Up-regulated SLC25A39 promotes cell growth and metastasis via regulating ROS production in colorectal cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.isci.2026.117098_bib36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41374-017-0004-5","article-title":"The mitochondrial nucleoside diphosphate kinase (NDPK-D\/NME4), a moonlighting protein for cell homeostasis","volume":"98","author":"Lacombe","year":"2018","journal-title":"Lab. Invest."},{"key":"10.1016\/j.isci.2026.117098_bib37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12915-021-01155-5","article-title":"The mitochondrially-localized nucleoside diphosphate kinase D (NME4) is a novel metastasis suppressor","volume":"19","author":"Lacombe","year":"2021","journal-title":"BMC Biol."},{"key":"10.1016\/j.isci.2026.117098_bib38","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10555-023-10165-4","article-title":"PRUNE1 and NME\/NDPK family proteins influence energy metabolism and signaling in cancer metastases","volume":"43","author":"Ferrucci","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.isci.2026.117098_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010008","article-title":"Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma","volume":"12","author":"Zhang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.117098_bib40","first-page":"1629","article-title":"NME4 may enhance non-small cell lung cancer progression by overcoming cell cycle arrest and promoting cellular proliferation","volume":"20","author":"Wang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.isci.2026.117098_bib41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3350\/cmh.2024.0236","article-title":"UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL","volume":"30","author":"Zhang","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.isci.2026.117098_bib42","article-title":"UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb","volume":"13","author":"Guo","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.117098_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13048-021-00877-y","article-title":"UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt\/\u03b2-catenin signaling pathway","volume":"14","author":"Hu","year":"2021","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.isci.2026.117098_bib44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41419-023-05938-2","article-title":"UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer","volume":"14","author":"Xiao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.117098_bib45","article-title":"Construction of ubiquitination-related risk model for predicting prognosis in lung adenocarcinoma","volume":"15","author":"Sun","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117098_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20708","article-title":"A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data","volume":"9","author":"Du","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.isci.2026.117098_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.654344","article-title":"Functional and Pathological Roles of AHCY","volume":"9","author":"Viz\u00e1n","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2026.117098_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112807","article-title":"MGL S3 Chimeric Enzyme Drives Apoptotic Death of EGFR-Dependent Cancer Cells through ERK Downregulation","volume":"23","author":"Bondarev","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117098_bib49","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1158\/1535-7163.MCT-10-0674","article-title":"Genome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisons","volume":"9","author":"Gmeiner","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.isci.2026.117098_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108135","article-title":"Spermidine synthase promotes liver cancer progression in a paracrine manner by altering the macrophage immunometabolic state","volume":"155","author":"Yu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.isci.2026.117098_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11716","article-title":"Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM","volume":"7","author":"Miao","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117098_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1253238","article-title":"PITX1 plays essential functions in cancer","volume":"13","author":"Zhao","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.117098_bib53","article-title":"PITX1 as a grading, prognostic and tumor-infiltrating immune cells marker for chondrosarcoma: a public database-based immunoassay and tissue sample analysis","volume":"15","author":"Huang","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.117098_bib54","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41588-021-00892-1","article-title":"Whole-exome imputation within UK Biobank powers rare coding variant association and fine-mapping analyses","volume":"53","author":"Barton","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.117098_bib55","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/ibd\/izy332","article-title":"Identification of New Potential Therapies for Colitis Amelioration Using an Appendicitis-Appendectomy Model","volume":"25","author":"Cheluvappa","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.isci.2026.117098_bib56","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s004390050368","article-title":"The human homolog of the rodent immediate early response genes, PC4 and TIS7, resides in the lung cancer tumor suppressor gene region on chromosome 3p21","volume":"99","author":"Latif","year":"1997","journal-title":"Hum. Genet."},{"key":"10.1016\/j.isci.2026.117098_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10974-024-09677-5","article-title":"IFRD2, a target of miR-2400, regulates myogenic differentiation of bovine skeletal muscle satellite cells via decreased phosphorylation of ERK1\/2 proteins","volume":"45","author":"Gong","year":"2024","journal-title":"J. Muscle Res. Cell Motil."},{"key":"10.1016\/j.isci.2026.117098_bib58","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","article-title":"Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117098_bib59","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/s12276-022-00896-9","article-title":"Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics","volume":"54","author":"Zhu","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.isci.2026.117098_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/JTO.0000000000000042","article-title":"Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients","volume":"9","author":"Der","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.isci.2026.117098_bib61","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","article-title":"Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas","volume":"72","author":"Okayama","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117098_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature04296","article-title":"Oncogenic pathway signatures in human cancers as a guide to targeted therapies","volume":"439","author":"Bild","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117098_bib63","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2026.117098_bib64","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2026.117098_bib65","doi-asserted-by":"crossref","first-page":"7995","DOI":"10.1038\/s41467-024-52356-9","article-title":"Context-aware single-cell multiomics approach identifies cell-type-specific lung cancer susceptibility genes","volume":"15","author":"Long","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117098_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140793","article-title":"Integration of single-cell and bulk RNA sequencing data using machine learning identifies oxidative stress-related genes LUM and PCOLCE2 as potential biomarkers for heart failure","volume":"300","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.isci.2026.117098_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae243","article-title":"irGSEA: the integration of single-cell rank-based gene set enrichment analysis","volume":"25","author":"Fan","year":"2024","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.isci.2026.117098_bib68","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s13167-023-00327-3","article-title":"Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework","volume":"14","author":"Liu","year":"2023","journal-title":"EPMA J."},{"key":"10.1016\/j.isci.2026.117098_bib69","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-025-02226-9","article-title":"Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4\/6 inhibition in patients with HR+\/HER2- metastatic breast cancer","volume":"24","author":"Luo","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2026.117098_bib70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41580-024-00768-2","article-title":"Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics","volume":"26","author":"Gulati","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.117098_bib71","article-title":"Polygenic regression uncovers trait-relevant cellular contexts through pathway activation transformation of single-cell RNA sequencing data","volume":"3","author":"Ma","year":"2023","journal-title":"Cell Genom."},{"key":"10.1016\/j.isci.2026.117098_bib72","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics","volume":"20","author":"Jin","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2026.117098_bib73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40364-024-00605-w","article-title":"Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma","volume":"12","author":"Dai","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.isci.2026.117098_bib74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12967-023-03872-7","article-title":"A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer","volume":"21","author":"Huang","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.117098_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103470","article-title":"Machine learning and SHAP value interpretation for predicting comorbidity of cardiovascular disease and cancer with dietary antioxidants","volume":"79","author":"Qi","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2026.117098_bib76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13073-021-01001-x","article-title":"Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data","volume":"13","author":"Fustero-Torre","year":"2021","journal-title":"Genome Med."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226024764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226024764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T21:58:34Z","timestamp":1794952714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226024764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589004226024764"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117098","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative multi-omics reveals a prognostic and therapeutic landscape of synthetic lethality-associated signatures in lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117098"}}